Russell Investments Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $65.6M | Sell |
973,800
-9,580
| -1% | -$638K | 0.06% | 323 |
|
|
2026
Q1 | $61.7M | Sell |
983,380
-30,109
| -3% | -$2.1M | 0.07% | 295 |
|
|
2025
Q4 | $67.3M | Buy |
1,013,489
+757,177
| +295% | +$49M | 0.07% | 263 |
|
|
2025
Q3 | $17.2M | Sell |
256,312
-198,857
| -44% | -$15.7M | 0.02% | 679 |
|
|
2025
Q2 | $39.7M | Buy |
455,169
+219,963
| +94% | +$17.2M | 0.05% | 382 |
|
|
2025
Q1 | $16M | Buy |
235,206
+91,525
| +64% | +$7.47M | 0.02% | 645 |
|
|
2024
Q4 | $11.2M | Buy |
143,681
+25,437
| +22% | +$1.88M | 0.02% | 761 |
|
|
2024
Q3 | $7.94M | Sell |
118,244
-8,675
| -7% | -$712K | 0.01% | 944 |
|
|
2024
Q2 | $14.4M | Buy |
126,919
+27,298
| +27% | +$3.45M | 0.02% | 650 |
|
|
2024
Q1 | $13.8M | Sell |
99,621
-41,384
| -29% | -$5.2M | 0.02% | 687 |
|
|
2023
Q4 | $17.5M | Sell |
141,005
-7,652
| -5% | -$782K | 0.03% | 557 |
|
|
2023
Q3 | $14M | Buy |
148,657
+27,168
| +22% | +$3.06M | 0.03% | 609 |
|
|
2023
Q2 | $15.6M | Sell |
121,489
-43,368
| -26% | -$5.25M | 0.03% | 574 |
|
|
2023
Q1 | $19.1M | Buy |
164,857
+39,982
| +32% | +$4.48M | 0.04% | 528 |
|
|
2022
Q4 | $14.1M | Buy |
124,875
+39,295
| +46% | +$4.31M | 0.03% | 635 |
|
|
2022
Q3 | $6.96M | Sell |
85,580
-16,608
| -16% | -$1.41M | 0.02% | 886 |
|
|
2022
Q2 | $7.65M | Sell |
102,188
-27,944
| -21% | -$2.55M | 0.02% | 878 |
|
|
2022
Q1 | $16.7M | Sell |
130,132
-197,796
| -60% | -$21.6M | 0.03% | 623 |
|
|
2021
Q4 | $44.1M | Sell |
327,928
-90,816
| -22% | -$13M | 0.07% | 328 |
|
|
2021
Q3 | $57.2M | Sell |
418,744
-19,740
| -5% | -$2.49M | 0.1% | 247 |
|
|
2021
Q2 | $46.8M | Sell |
438,484
-26,520
| -6% | -$2.55M | 0.08% | 312 |
|
|
2021
Q1 | $41.7M | Sell |
465,004
-124,032
| -21% | -$11.6M | 0.07% | 324 |
|
|
2020
Q4 | $54.2M | Buy |
589,036
+102,100
| +21% | +$9.12M | 0.11% | 213 |
|
|
2020
Q3 | $50.1M | Sell |
486,936
-49,032
| -9% | -$5.12M | 0.11% | 206 |
|
|
2020
Q2 | $54.2M | Sell |
535,968
-168,220
| -24% | -$15M | 0.12% | 184 |
|
|
2020
Q1 | $47.6M | Buy |
704,188
+603,608
| +600% | +$37.6M | 0.12% | 185 |
|
|
2019
Q4 | $5.47M | Buy |
100,580
+11,040
| +12% | +$524K | 0.01% | 1156 |
|
|
2019
Q3 | $3.34M | Buy |
89,540
+4,700
| +6% | +$183K | 0.01% | 1402 |
|
|
2019
Q2 | $3.16M | Sell |
84,840
-11,500
| -12% | -$361K | 0.01% | 1448 |
|
|
2019
Q1 | $2.87M | Sell |
96,340
-72,356
| -43% | -$2.54M | 0.01% | 1531 |
|
|
2018
Q4 | $5.01M | Sell |
168,696
-49,596
| -23% | -$1.57M | 0.01% | 1144 |
|
|
2018
Q3 | $7.81M | Buy |
218,292
+52,160
| +31% | +$1.62M | 0.01% | 1064 |
|
|
2018
Q2 | $3.94M | Sell |
166,132
-195,744
| -54% | -$4.15M | 0.01% | 1400 |
|
|
2018
Q1 | $6.71M | Sell |
361,876
-1,018,508
| -74% | -$15.1M | 0.01% | 1192 |
|
|
2017
Q4 | $19.8M | Buy |
1,380,384
+44,472
| +3% | +$578K | 0.03% | 651 |
|
|
2017
Q3 | $16.3M | Buy |
1,335,912
+1,232,392
| +1,190% | +$21.8M | 0.03% | 719 |
|
|
2017
Q2 | $1.89M | Sell |
103,520
-99,964
| -49% | -$1.85M | ﹤0.01% | 1767 |
|
|
2017
Q1 | $4.31M | Sell |
203,484
-345,308
| -63% | -$6.74M | 0.01% | 1303 |
|
|
2016
Q4 | $8.31M | Buy |
+548,792
| New | +$9.72M | 0.02% | 949 |
|
Other funds holding DXCM
Russell Investments Group's DXCM Position: Q2 2026 in Review
Russell Investments Group reduced its DexCom (DXCM) stake by 0.97% in Q2 2026, selling an estimated $638K and leaving 973,800 shares worth $65.6M. The position accounts for 0.06% of the portfolio, ranked #323.
Russell Investments Group first reported a position in DXCM in Q4 2016 and has held it in 39 quarters since. The position peaked at $67.3M in Q4 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Russell Investments Group held 973,800 shares of DexCom worth $65.6M as of Q2 2026.
- Russell Investments Group sold 9,580 DexCom shares in Q2 2026, an estimated $638K.
- DexCom made up 0.06% of Russell Investments Group's portfolio in Q2 2026, its #323 holding.
- Russell Investments Group first reported a position in DexCom in Q4 2016 and has held it in 39 quarters since.
- Russell Investments Group's DexCom position peaked at $67.3M in Q4 2025.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.